市場調査レポート

商品コード

1140001

コンパニオンアニマル診断市場：技術別、用途別、動物種別、エンドユーザー別：世界の機会分析および産業予測、2021-2031年

Companion Animal Diagnostics Market By Technology, By Application, By Animal Type, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031

出版日: 2022年07月01日 | 発行: Allied Market Research

| ページ情報: 英文 380 Pages | 納期: 2～3営業日

価格

PDF (Single User License)

USD 6,090 954,668円

レポートPDFを1つのPCでご利用頂けるライセンスです。ライセンスを付与されたPCでのみレポートPDFの保存、表示、利用が可能です。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は1回だけ可能です。印刷したレポートの利用もPDFのライセンス保持者になります。回覧のための複製も原則NGです。

PDF (5-user License)

USD 6,630 1,039,318円

レポートPDFを5名でご利用頂けるライセンスです。ライセンスを付与されたPCでのみレポートPDFの保存、表示、利用が可能です。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は5回可能です。印刷したレポートの利用もPDFのライセンス保持者5名となります。

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

USD 10,500 1,645,980円

レポートPDFとExcel定量データをひとつの企業、及びその子会社でご利用頂けるライセンスです。ライセンスを付与されたPCでのみレポートPDFとExcelの保存、表示、利用が可能です。PDFとExcel内のテキスト等のコピー＆ペーストは可能です。PDFとExcelの印刷回数の制限はありません。印刷したレポートの利用は企業、及びその子会社内にて共有可能です。無料でレポートのアップデートがご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

コンパニオンアニマル診断の世界市場は、2021年に29億8980万米ドル、2031年には68億8467万米ドルに達し、2022年から2031年までのCAGRは8.6%を記録すると予測されています。

コンパニオンアニマル診断とは、コンパニオンアニマルの慢性疾患を分子レベルで特定するための診断方法です。コンパニオンアニマル診断は、動物の様々な慢性疾患を特定＆特徴付けるための最良の方法であると考えられています。病気の検出には、分子診断、免疫診断、臨床生化学、尿検査など、さまざまな診断方法が用いられます。

市場の成長を促進する主な要因は、動物医療費の増加、ペットの飼育率の上昇、人獣共通感染症である癌、消化器系疾患などの慢性疾患の有病率の増加です。例えば、米国疾病対策予防センターが発表したレポートによると、人獣共通感染症は米国をはじめ世界中で非常によく見られるものであり、10頭中約6頭が人獣共通感染症の影響を受けていると推定されています。さらに、動物ヘルスケアに関連する意識の高まり、ポイントオブケア診断のための迅速検査やポータブル機器の採用の増加が、主要な業界プレーヤーに有利な機会を提供する主な要因となっています。しかし、熟練した獣医の専門家や動物の健康に対する意識の欠如は、今後数年間の市場の成長を阻害する要因となっています。

概要
- 市場規模・予測
臨床生化学
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
免疫診断学
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
分子生物学的診断法
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
血液学
- 主要な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
尿検査
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
その他
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別

第5章コンパニオンアニマル診断市場：アプリケーション別

概要
- 市場規模・予測
クリニカルパソロジー
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
細菌学
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
ウイルス学
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
寄生虫学
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
その他のアプリケーション
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別

第6章コンパニオンアニマル診断市場：動物タイプ別

概要
- 市場規模・予測
犬
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
猫
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
その他
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別

第7章コンパニオンアニマル診断市場：エンドユーザー別

概要
- 市場規模・予測
診断ラボ
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
動物病院・診療所
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
ポイントオブケアとインハウステスト
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
調査機関および大学
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別

第8章コンパニオンアニマル診断市場：地域別

概要
- 市場規模・予測
北米
- 主な動向と機会
- 北米市場規模・予測：技術別
- 北米市場規模・予測：アプリケーション別
- 北米市場規模・予測：動物タイプ別
- 北米市場規模・予測：エンドユーザー別
- 北米市場規模・予測：国別
  - 米国
  - カナダ
  - メキシコ
欧州
- 主な動向と機会
- 欧州の市場規模・予測：技術別
- 欧州市場規模・予測：アプリケーション別
- 欧州市場規模・予測：動物タイプ別
- 欧州市場規模・予測：エンドユーザー別
- 欧州市場規模・予測：国別
  - ドイツ
  - フランス
  - 英国
  - イタリア
  - スペイン
  - その他の欧州地域
アジア太平洋地域
- 主な動向と機会
- アジア太平洋地域の市場規模・予測：技術別
- アジア太平洋地域の市場規模・予測：アプリケーション別
- アジア太平洋地域の市場規模・予測：動物タイプ別
- アジア太平洋地域の市場規模・予測：エンドユーザー別
- アジア太平洋地域の市場規模・予測：国別
  - 日本
  - 中国
  - オーストラリア
  - インド
  - 韓国
  - その他アジア太平洋地域
LAMEA
- 主な動向と機会
- LAMEAの市場規模・予測：技術別
- LAMEAの市場規模・予測：アプリケーション別
- LAMEAの市場規模・予測：動物タイプ別
- LAMEAの市場規模・予測：エンドユーザー別
- LAMEA市場の市場規模・予測：国別
  - ブラジル
  - サウジアラビア
  - 南アフリカ共和国
  - LAMEAの残りの地域

第9章企業情勢

イントロダクション
主要成功戦略
主要10社の製品マッピング
競合ダッシュボード
競合のヒートマップ
主な発展

第10章企業プロファイル

Virbac
Thermo Fisher Scientific, Inc
Zoetis, Inc
agrolabo spa
Biomerieux SA
BioNote Inc
Creative Diagnostics
Fujifilm Holdings Corporation
Heska Corporation
HyTest Ltd
Idexx Laboratories Inc
IDvet
Indical Bioscience Gmbh
Neogen Corporation
Randox Laboratories Ltd
Shenzhen Mindray Animal Medical Technology Co. Ltd
Triviumvet

図表

LIST OF TABLES

TABLE 1. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 2. COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, FOR CLINICAL BIOCHEMISTRY, BY REGION, 2021-2031 ($MILLION)
TABLE 3. COMPANION ANIMAL DIAGNOSTICS MARKET FOR CLINICAL BIOCHEMISTRY, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 4. COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, FOR IMMUNODIAGNOSTICS, BY REGION, 2021-2031 ($MILLION)
TABLE 5. COMPANION ANIMAL DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 6. COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, FOR MOLECULAR DIAGNOSTICS, BY REGION, 2021-2031 ($MILLION)
TABLE 7. COMPANION ANIMAL DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 8. COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, FOR HEMATOLOGY, BY REGION, 2021-2031 ($MILLION)
TABLE 9. COMPANION ANIMAL DIAGNOSTICS MARKET FOR HEMATOLOGY, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 10. COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, FOR URINALYSIS, BY REGION, 2021-2031 ($MILLION)
TABLE 11. COMPANION ANIMAL DIAGNOSTICS MARKET FOR URINALYSIS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 12. COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 13. COMPANION ANIMAL DIAGNOSTICS MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 14. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 15. COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, FOR CLINICAL PATHOLOGY, BY REGION, 2021-2031 ($MILLION)
TABLE 16. COMPANION ANIMAL DIAGNOSTICS MARKET FOR CLINICAL PATHOLOGY, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 17. COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, FOR BACTERIOLOGY, BY REGION, 2021-2031 ($MILLION)
TABLE 18. COMPANION ANIMAL DIAGNOSTICS MARKET FOR BACTERIOLOGY, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 19. COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, FOR VIROLOGY, BY REGION, 2021-2031 ($MILLION)
TABLE 20. COMPANION ANIMAL DIAGNOSTICS MARKET FOR VIROLOGY, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 21. COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, FOR PARASITOLOGY, BY REGION, 2021-2031 ($MILLION)
TABLE 22. COMPANION ANIMAL DIAGNOSTICS MARKET FOR PARASITOLOGY, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 23. COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, FOR OTHER APPLICATIONS, BY REGION, 2021-2031 ($MILLION)
TABLE 24. COMPANION ANIMAL DIAGNOSTICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 25. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2031 ($MILLION)
TABLE 26. COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, FOR DOGS, BY REGION, 2021-2031 ($MILLION)
TABLE 27. COMPANION ANIMAL DIAGNOSTICS MARKET FOR DOGS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 28. COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, FOR CATS, BY REGION, 2021-2031 ($MILLION)
TABLE 29. COMPANION ANIMAL DIAGNOSTICS MARKET FOR CATS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 30. COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 31. COMPANION ANIMAL DIAGNOSTICS MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 32. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 33. COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, FOR DIAGNOSTIC LABS, BY REGION, 2021-2031 ($MILLION)
TABLE 34. COMPANION ANIMAL DIAGNOSTICS MARKET FOR DIAGNOSTIC LABS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 35. COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, FOR VETERINARY HOSPITALS AND CLINICS, BY REGION, 2021-2031 ($MILLION)
TABLE 36. COMPANION ANIMAL DIAGNOSTICS MARKET FOR VETERINARY HOSPITALS AND CLINICS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 37. COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, FOR POINT-OF-CARE AND IN-HOUSE TESTING, BY REGION, 2021-2031 ($MILLION)
TABLE 38. COMPANION ANIMAL DIAGNOSTICS MARKET FOR POINT-OF-CARE AND IN-HOUSE TESTING, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 39. COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, FOR RESEARCH INSTITUTES AND UNIVERSITIES, BY REGION, 2021-2031 ($MILLION)
TABLE 40. COMPANION ANIMAL DIAGNOSTICS MARKET FOR RESEARCH INSTITUTES AND UNIVERSITIES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 41. COMPANION ANIMAL DIAGNOSTICS MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 42. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 43. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 44. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2031 ($MILLION)
TABLE 45. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 46. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 47. U.S. COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 48. U.S. COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 49. U.S. COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2031 ($MILLION)
TABLE 50. U.S. COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 51. CANADA COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 52. CANADA COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 53. CANADA COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2031 ($MILLION)
TABLE 54. CANADA COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 55. MEXICO COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 56. MEXICO COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 57. MEXICO COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2031 ($MILLION)
TABLE 58. MEXICO COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 59. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 60. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 61. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2031 ($MILLION)
TABLE 62. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 63. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 64. GERMANY COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 65. GERMANY COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 66. GERMANY COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2031 ($MILLION)
TABLE 67. GERMANY COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 68. FRANCE COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 69. FRANCE COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 70. FRANCE COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2031 ($MILLION)
TABLE 71. FRANCE COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 72. U.K. COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 73. U.K. COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 74. U.K. COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2031 ($MILLION)
TABLE 75. U.K. COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 76. ITALY COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 77. ITALY COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 78. ITALY COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2031 ($MILLION)
TABLE 79. ITALY COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 80. SPAIN COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 81. SPAIN COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 82. SPAIN COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2031 ($MILLION)
TABLE 83. SPAIN COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 84. REST OF EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 85. REST OF EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 86. REST OF EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2031 ($MILLION)
TABLE 87. REST OF EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 88. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 89. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 90. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2031 ($MILLION)
TABLE 91. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 92. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 93. JAPAN COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 94. JAPAN COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 95. JAPAN COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2031 ($MILLION)
TABLE 96. JAPAN COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 97. CHINA COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 98. CHINA COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 99. CHINA COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2031 ($MILLION)
TABLE 100. CHINA COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 101. AUSTRALIA COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 102. AUSTRALIA COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 103. AUSTRALIA COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2031 ($MILLION)
TABLE 104. AUSTRALIA COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 105. INDIA COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 106. INDIA COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 107. INDIA COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2031 ($MILLION)
TABLE 108. INDIA COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 109. SOUTH KOREA COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 110. SOUTH KOREA COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 111. SOUTH KOREA COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2031 ($MILLION)
TABLE 112. SOUTH KOREA COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 113. REST OF ASIA PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 114. REST OF ASIA PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 115. REST OF ASIA PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2031 ($MILLION)
TABLE 116. REST OF ASIA PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 117. LAMEA COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 118. LAMEA COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 119. LAMEA COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2031 ($MILLION)
TABLE 120. LAMEA COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 121. LAMEA COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 122. BRAZIL COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 123. BRAZIL COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 124. BRAZIL COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2031 ($MILLION)
TABLE 125. BRAZIL COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 126. SAUDI ARABIA COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 127. SAUDI ARABIA COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 128. SAUDI ARABIA COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2031 ($MILLION)
TABLE 129. SAUDI ARABIA COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 130. SOUTH AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 131. SOUTH AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 132. SOUTH AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2031 ($MILLION)
TABLE 133. SOUTH AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 134. REST OF LAMEA COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 135. REST OF LAMEA COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 136. REST OF LAMEA COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021-2031 ($MILLION)
TABLE 137. REST OF LAMEA COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 138.VIRBAC: COMPANY SNAPSHOT
TABLE 139.VIRBAC: OPERATING SEGMENTS
TABLE 140.VIRBAC: PRODUCT PORTFOLIO
TABLE 141.VIRBAC: NET SALES,
TABLE 142.VIRBAC: KEY STRATERGIES
TABLE 143.THERMO FISHER SCIENTIFIC, INC: COMPANY SNAPSHOT
TABLE 144.THERMO FISHER SCIENTIFIC, INC: OPERATING SEGMENTS
TABLE 145.THERMO FISHER SCIENTIFIC, INC: PRODUCT PORTFOLIO
TABLE 146.THERMO FISHER SCIENTIFIC, INC: NET SALES,
TABLE 147.THERMO FISHER SCIENTIFIC, INC: KEY STRATERGIES
TABLE 148.ZOETIS, INC: COMPANY SNAPSHOT
TABLE 149.ZOETIS, INC: OPERATING SEGMENTS
TABLE 150.ZOETIS, INC: PRODUCT PORTFOLIO
TABLE 151.ZOETIS, INC: NET SALES,
TABLE 152.ZOETIS, INC: KEY STRATERGIES
TABLE 153.AGROLABO SPA: COMPANY SNAPSHOT
TABLE 154.AGROLABO SPA: OPERATING SEGMENTS
TABLE 155.AGROLABO SPA: PRODUCT PORTFOLIO
TABLE 156.AGROLABO SPA: NET SALES,
TABLE 157.AGROLABO SPA: KEY STRATERGIES
TABLE 158.BIOMERIEUX SA: COMPANY SNAPSHOT
TABLE 159.BIOMERIEUX SA: OPERATING SEGMENTS
TABLE 160.BIOMERIEUX SA: PRODUCT PORTFOLIO
TABLE 161.BIOMERIEUX SA: NET SALES,
TABLE 162.BIOMERIEUX SA: KEY STRATERGIES
TABLE 163.BIONOTE INC: COMPANY SNAPSHOT
TABLE 164.BIONOTE INC: OPERATING SEGMENTS
TABLE 165.BIONOTE INC: PRODUCT PORTFOLIO
TABLE 166.BIONOTE INC: NET SALES,
TABLE 167.BIONOTE INC: KEY STRATERGIES
TABLE 168.CREATIVE DIAGNOSTICS: COMPANY SNAPSHOT
TABLE 169.CREATIVE DIAGNOSTICS: OPERATING SEGMENTS
TABLE 170.CREATIVE DIAGNOSTICS: PRODUCT PORTFOLIO
TABLE 171.CREATIVE DIAGNOSTICS: NET SALES,
TABLE 172.CREATIVE DIAGNOSTICS: KEY STRATERGIES
TABLE 173.FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT
TABLE 174.FUJIFILM HOLDINGS CORPORATION: OPERATING SEGMENTS
TABLE 175.FUJIFILM HOLDINGS CORPORATION: PRODUCT PORTFOLIO
TABLE 176.FUJIFILM HOLDINGS CORPORATION: NET SALES,
TABLE 177.FUJIFILM HOLDINGS CORPORATION: KEY STRATERGIES
TABLE 178.HESKA CORPORATION: COMPANY SNAPSHOT
TABLE 179.HESKA CORPORATION: OPERATING SEGMENTS
TABLE 180.HESKA CORPORATION: PRODUCT PORTFOLIO
TABLE 181.HESKA CORPORATION: NET SALES,
TABLE 182.HESKA CORPORATION: KEY STRATERGIES
TABLE 183.HYTEST LTD: COMPANY SNAPSHOT
TABLE 184.HYTEST LTD: OPERATING SEGMENTS
TABLE 185.HYTEST LTD: PRODUCT PORTFOLIO
TABLE 186.HYTEST LTD: NET SALES,
TABLE 187.HYTEST LTD: KEY STRATERGIES
TABLE 188.IDEXX LABORATORIES INC: COMPANY SNAPSHOT
TABLE 189.IDEXX LABORATORIES INC: OPERATING SEGMENTS
TABLE 190.IDEXX LABORATORIES INC: PRODUCT PORTFOLIO
TABLE 191.IDEXX LABORATORIES INC: NET SALES,
TABLE 192.IDEXX LABORATORIES INC: KEY STRATERGIES
TABLE 193.IDVET: COMPANY SNAPSHOT
TABLE 194.IDVET: OPERATING SEGMENTS
TABLE 195.IDVET: PRODUCT PORTFOLIO
TABLE 196.IDVET: NET SALES,
TABLE 197.IDVET: KEY STRATERGIES
TABLE 198.INDICAL BIOSCIENCE GMBH: COMPANY SNAPSHOT
TABLE 199.INDICAL BIOSCIENCE GMBH: OPERATING SEGMENTS
TABLE 200.INDICAL BIOSCIENCE GMBH: PRODUCT PORTFOLIO
TABLE 201.INDICAL BIOSCIENCE GMBH: NET SALES,
TABLE 202.INDICAL BIOSCIENCE GMBH: KEY STRATERGIES
TABLE 203.NEOGEN CORPORATION: COMPANY SNAPSHOT
TABLE 204.NEOGEN CORPORATION: OPERATING SEGMENTS
TABLE 205.NEOGEN CORPORATION: PRODUCT PORTFOLIO
TABLE 206.NEOGEN CORPORATION: NET SALES,
TABLE 207.NEOGEN CORPORATION: KEY STRATERGIES
TABLE 208.RANDOX LABORATORIES LTD: COMPANY SNAPSHOT
TABLE 209.RANDOX LABORATORIES LTD: OPERATING SEGMENTS
TABLE 210.RANDOX LABORATORIES LTD: PRODUCT PORTFOLIO
TABLE 211.RANDOX LABORATORIES LTD: NET SALES,
TABLE 212.RANDOX LABORATORIES LTD: KEY STRATERGIES
TABLE 213.SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO. LTD: COMPANY SNAPSHOT
TABLE 214.SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO. LTD: OPERATING SEGMENTS
TABLE 215.SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO. LTD: PRODUCT PORTFOLIO
TABLE 216.SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO. LTD: NET SALES,
TABLE 217.SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO. LTD: KEY STRATERGIES
TABLE 218.TRIVIUMVET: COMPANY SNAPSHOT
TABLE 219.TRIVIUMVET: OPERATING SEGMENTS
TABLE 220.TRIVIUMVET: PRODUCT PORTFOLIO
TABLE 221.TRIVIUMVET: NET SALES,
TABLE 222.TRIVIUMVET: KEY STRATERGIES

LIST OF FIGURES

FIGURE 1.COMPANION ANIMAL DIAGNOSTICS MARKET SEGMENTATION
FIGURE 2.COMPANION ANIMAL DIAGNOSTICS MARKET,2021-2031
FIGURE 3.COMPANION ANIMAL DIAGNOSTICS MARKET,2021-2031
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.COMPANION ANIMAL DIAGNOSTICS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 12.COMPANION ANIMAL DIAGNOSTICS MARKET,BY TECHNOLOGY,2021(%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF CLINICAL BIOCHEMISTRY COMPANION ANIMAL DIAGNOSTICS MARKET,2021-2031(%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF IMMUNODIAGNOSTICS COMPANION ANIMAL DIAGNOSTICS MARKET,2021-2031(%)
FIGURE 15.COMPARATIVE SHARE ANALYSIS OF MOLECULAR DIAGNOSTICS COMPANION ANIMAL DIAGNOSTICS MARKET,2021-2031(%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF HEMATOLOGY COMPANION ANIMAL DIAGNOSTICS MARKET,2021-2031(%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF URINALYSIS COMPANION ANIMAL DIAGNOSTICS MARKET,2021-2031(%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF OTHERS COMPANION ANIMAL DIAGNOSTICS MARKET,2021-2031(%)
FIGURE 19.COMPANION ANIMAL DIAGNOSTICS MARKET,BY APPLICATION,2021(%)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF CLINICAL PATHOLOGY COMPANION ANIMAL DIAGNOSTICS MARKET,2021-2031(%)
FIGURE 21.COMPARATIVE SHARE ANALYSIS OF BACTERIOLOGY COMPANION ANIMAL DIAGNOSTICS MARKET,2021-2031(%)
FIGURE 22.COMPARATIVE SHARE ANALYSIS OF VIROLOGY COMPANION ANIMAL DIAGNOSTICS MARKET,2021-2031(%)
FIGURE 23.COMPARATIVE SHARE ANALYSIS OF PARASITOLOGY COMPANION ANIMAL DIAGNOSTICS MARKET,2021-2031(%)
FIGURE 24.COMPARATIVE SHARE ANALYSIS OF OTHER APPLICATIONS COMPANION ANIMAL DIAGNOSTICS MARKET,2021-2031(%)
FIGURE 25.COMPANION ANIMAL DIAGNOSTICS MARKET,BY ANIMAL TYPE,2021(%)
FIGURE 26.COMPARATIVE SHARE ANALYSIS OF DOGS COMPANION ANIMAL DIAGNOSTICS MARKET,2021-2031(%)
FIGURE 27.COMPARATIVE SHARE ANALYSIS OF CATS COMPANION ANIMAL DIAGNOSTICS MARKET,2021-2031(%)
FIGURE 28.COMPARATIVE SHARE ANALYSIS OF OTHERS COMPANION ANIMAL DIAGNOSTICS MARKET,2021-2031(%)
FIGURE 29.COMPANION ANIMAL DIAGNOSTICS MARKET,BY END USER,2021(%)
FIGURE 30.COMPARATIVE SHARE ANALYSIS OF DIAGNOSTIC LABS COMPANION ANIMAL DIAGNOSTICS MARKET,2021-2031(%)
FIGURE 31.COMPARATIVE SHARE ANALYSIS OF VETERINARY HOSPITALS AND CLINICS COMPANION ANIMAL DIAGNOSTICS MARKET,2021-2031(%)
FIGURE 32.COMPARATIVE SHARE ANALYSIS OF POINT-OF-CARE AND IN-HOUSE TESTING COMPANION ANIMAL DIAGNOSTICS MARKET,2021-2031(%)
FIGURE 33.COMPARATIVE SHARE ANALYSIS OF RESEARCH INSTITUTES AND UNIVERSITIES COMPANION ANIMAL DIAGNOSTICS MARKET,2021-2031(%)
FIGURE 34.COMPANION ANIMAL DIAGNOSTICS MARKET BY REGION,2021
FIGURE 35.U.S. COMPANION ANIMAL DIAGNOSTICS MARKET,2021-2031($MILLION)
FIGURE 36.CANADA COMPANION ANIMAL DIAGNOSTICS MARKET,2021-2031($MILLION)
FIGURE 37.MEXICO COMPANION ANIMAL DIAGNOSTICS MARKET,2021-2031($MILLION)
FIGURE 38.GERMANY COMPANION ANIMAL DIAGNOSTICS MARKET,2021-2031($MILLION)
FIGURE 39.FRANCE COMPANION ANIMAL DIAGNOSTICS MARKET,2021-2031($MILLION)
FIGURE 40.U.K. COMPANION ANIMAL DIAGNOSTICS MARKET,2021-2031($MILLION)
FIGURE 41.ITALY COMPANION ANIMAL DIAGNOSTICS MARKET,2021-2031($MILLION)
FIGURE 42.SPAIN COMPANION ANIMAL DIAGNOSTICS MARKET,2021-2031($MILLION)
FIGURE 43.REST OF EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET,2021-2031($MILLION)
FIGURE 44.JAPAN COMPANION ANIMAL DIAGNOSTICS MARKET,2021-2031($MILLION)
FIGURE 45.CHINA COMPANION ANIMAL DIAGNOSTICS MARKET,2021-2031($MILLION)
FIGURE 46.AUSTRALIA COMPANION ANIMAL DIAGNOSTICS MARKET,2021-2031($MILLION)
FIGURE 47.INDIA COMPANION ANIMAL DIAGNOSTICS MARKET,2021-2031($MILLION)
FIGURE 48.SOUTH KOREA COMPANION ANIMAL DIAGNOSTICS MARKET,2021-2031($MILLION)
FIGURE 49.REST OF ASIA PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET,2021-2031($MILLION)
FIGURE 50.BRAZIL COMPANION ANIMAL DIAGNOSTICS MARKET,2021-2031($MILLION)
FIGURE 51.SAUDI ARABIA COMPANION ANIMAL DIAGNOSTICS MARKET,2021-2031($MILLION)
FIGURE 52.SOUTH AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET,2021-2031($MILLION)
FIGURE 53.REST OF LAMEA COMPANION ANIMAL DIAGNOSTICS MARKET,2021-2031($MILLION)
FIGURE 54. TOP WINNING STRATEGIES, BY YEAR
FIGURE 55. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 56. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 57.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 58.COMPETITIVE DASHBOARD
FIGURE 59.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 60.VIRBAC.: NET SALES ,($MILLION)
FIGURE 61.THERMO FISHER SCIENTIFIC, INC.: NET SALES ,($MILLION)
FIGURE 62.ZOETIS, INC.: NET SALES ,($MILLION)
FIGURE 63.AGROLABO SPA.: NET SALES ,($MILLION)
FIGURE 64.BIOMERIEUX SA.: NET SALES ,($MILLION)
FIGURE 65.BIONOTE INC.: NET SALES ,($MILLION)
FIGURE 66.CREATIVE DIAGNOSTICS.: NET SALES ,($MILLION)
FIGURE 67.FUJIFILM HOLDINGS CORPORATION.: NET SALES ,($MILLION)
FIGURE 68.HESKA CORPORATION.: NET SALES ,($MILLION)
FIGURE 69.HYTEST LTD.: NET SALES ,($MILLION)
FIGURE 70.IDEXX LABORATORIES INC.: NET SALES ,($MILLION)
FIGURE 71.IDVET.: NET SALES ,($MILLION)
FIGURE 72.INDICAL BIOSCIENCE GMBH.: NET SALES ,($MILLION)
FIGURE 73.NEOGEN CORPORATION.: NET SALES ,($MILLION)
FIGURE 74.RANDOX LABORATORIES LTD.: NET SALES ,($MILLION)
FIGURE 75.SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO. LTD.: NET SALES ,($MILLION)
FIGURE 76.TRIVIUMVET.: NET SALES ,($MILLION)

Product Code: A11127

The global companion animal diagnostics market was valued at $2,989.8 million in 2021, and is projected to reach $6,884.67 million by 2031, registering a CAGR of 8.6% from 2022 to 2031.

Companion animal diagnostics is a diagnostic method that is used to identify a chronic disease in companion animals at the molecular level. Companion animal diagnosis is considered to be the best method to identify & characterize various chronic diseases in animals. For the detection of diseases, several diagnostics method are used such as molecular diagnostic, immunodiagnostic, Clinical biochemistry, uranalysis and among others.

The key factors that drive the growth of the market are an increase in animal healthcare expenditure, rise in pet adoption, and an increase in the prevalence of chronic diseases such as zoonotic disease cancer, gastrointestinal disease, and others. For instance, according to a report published by the Center for Disease Control and Prevention, zoonotic diseases are very common, both in the United States and around the world and it was estimated that about 6 out of every 10 animal is affected by a zoonotic disease. Furthermore, the rise in awareness associated with animal healthcare, and the rise in the adoption of rapid tests and portable instruments for point-of-care diagnostics are the key factors that provide lucrative opportunities for key industry players. However, the lack of skilled veterinary professionals and animal health awareness hinders the growth of the market in upcoming years.

The companion animal diagnostics market is segmented on the basis of technology, application, animal type, end-use, and region. By technology, the market is segmented into clinical biochemistry, immunodiagnostics, hematology, molecular diagnostics, urinalysis, and others. The basis of clinical biochemistry is further sub-segmented into clinical chemistry analyzers, blood gas & electrolyte analysis, and glucose monitoring. Immunodiagnostics is sub-segmented into ELISA, lateral flow assay, immunoassay analyzer, and other (rapid test, western blot tests, immunohistochemistry, allergen-specific immunodiagnostic tests diagnostics). Hematology is further bifurcated into hematology cartridges and hematology analyzers. Molecular diagnostics is sub-segmented into PCR, microarray, and others. Urinalysis is sub-segmented into urinalysis clips & cartridges/panels, urine analyzers, and urine test strips. And on the basis of others, the technology market for companion animal diagnostics is bifurcated into microbiology tests and histopathology tests. On the basis of application, the market is segmented into bacteriology, clinical pathology, virology, parasitology, and others. On the basis of animal type, the market is bifurcated into dogs, cats, and others. By end use, the market is segmented into diagnostics laboratories, veterinary healthcare and clinics, research institute, and point of care. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

North America accounted for the largest market share in 2021 and is anticipated to remain dominant during the forecast period. Owing to rise in the adoption of pets in North America and the rise in the prevalence of various chronic diseases among animals drive the growth of the companion animal diagnostics market. Asia-Pacific is anticipated to witness lucrative growth, owing to a surge in the companion animal population, growing demand for diagnostics services from the livestock industry, and rise in companion animal health expenditure among emerging countries across APAC is expected to offer significant growth for the market

The key players that operate in the companion animal diagnostics market are Agrolabo SpA, Biomerieux SA, BioNote Inc. Creative Diagnostics, Fujifilm Holdings Corporation, Heska Corporation, HyTest Ltd., Idexx Laboratories Inc., IDvet, Indical Bioscience Gmbh, Neogen Corporation, Randox Laboratories Ltd., Shenzhen Mindray Animal Medical Technology Co. Ltd, Thermofisher Scientifc Inc., Triviumvet, Virbac and Zoetis Inc.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the companion animal diagnostics market analysis from 2021 to 2031 to identify the prevailing companion animal diagnostics market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the companion animal diagnostics market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global companion animal diagnostics market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Technology

Clinical Biochemistry
- Clinical Chemistry Analyzer
- Blood Glucose Monitoring
- Blood Gas Electrolyte Analysis
Immunodiagnostics
- ELISA
- Lateral Flow Assay
- Immunoassay Analyzers
- Others
Hematology
- Hematology Cartridges
- Hematology Analyzers
Molecular Diagnostics
- PCR
- Microarrays
- Others
Urinalysis
- Urinalysis clips cartridges/panels
- Urine Analyzer
- Urine Test Strips
Others

By Application

Clinical Pathology
Bacteriology
Virology
Parasitology
Other Applications

By Animal Type

Dogs
Cats
Others

By End User

Diagnostic Labs
Point-Of-Care and In-House Testing
Research Institutes and Universities
Veterinary Hospitals and Clinics

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest Of Asia Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Virbac
- Thermo Fisher Scientific, Inc
- Zoetis, Inc
- agrolabo spa
- Biomerieux SA
- BioNote Inc
- Creative Diagnostics
- Fujifilm Holdings Corporation
- Heska Corporation
- HyTest Ltd
- Idexx Laboratories Inc
- IDvet
- Indical Bioscience Gmbh
- Neogen Corporation
- Randox Laboratories Ltd
- Shenzhen Mindray Animal Medical Technology Co. Ltd
- Triviumvet

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings
- 3.2.1.Top investment pockets
3.3.Porter's five forces analysis
3.4.Top player positioning
3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY

4.1 Overview
- 4.1.1 Market size and forecast
4.2 Clinical Biochemistry
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
4.3 Immunodiagnostics
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
4.4 Molecular Diagnostics
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market analysis by country
4.5 Hematology
- 4.5.1 Key market trends, growth factors and opportunities
- 4.5.2 Market size and forecast, by region
- 4.5.3 Market analysis by country
4.6 Urinalysis
- 4.6.1 Key market trends, growth factors and opportunities
- 4.6.2 Market size and forecast, by region
- 4.6.3 Market analysis by country
4.7 Others
- 4.7.1 Key market trends, growth factors and opportunities
- 4.7.2 Market size and forecast, by region
- 4.7.3 Market analysis by country

CHAPTER 5: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION

5.1 Overview
- 5.1.1 Market size and forecast
5.2 Clinical Pathology
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
5.3 Bacteriology
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
5.4 Virology
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
5.5 Parasitology
- 5.5.1 Key market trends, growth factors and opportunities
- 5.5.2 Market size and forecast, by region
- 5.5.3 Market analysis by country
5.6 Other Applications
- 5.6.1 Key market trends, growth factors and opportunities
- 5.6.2 Market size and forecast, by region
- 5.6.3 Market analysis by country

CHAPTER 6: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE

6.1 Overview
- 6.1.1 Market size and forecast
6.2 Dogs
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
6.3 Cats
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
6.4 Others
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country

CHAPTER 7: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER

7.1 Overview
- 7.1.1 Market size and forecast
7.2 Diagnostic Labs
- 7.2.1 Key market trends, growth factors and opportunities
- 7.2.2 Market size and forecast, by region
- 7.2.3 Market analysis by country
7.3 Veterinary Hospitals and Clinics
- 7.3.1 Key market trends, growth factors and opportunities
- 7.3.2 Market size and forecast, by region
- 7.3.3 Market analysis by country
7.4 Point-Of-Care and In-House Testing
- 7.4.1 Key market trends, growth factors and opportunities
- 7.4.2 Market size and forecast, by region
- 7.4.3 Market analysis by country
7.5 Research Institutes and Universities
- 7.5.1 Key market trends, growth factors and opportunities
- 7.5.2 Market size and forecast, by region
- 7.5.3 Market analysis by country

CHAPTER 8: COMPANION ANIMAL DIAGNOSTICS MARKET, BY REGION

8.1 Overview
- 8.1.1 Market size and forecast
8.2 North America
- 8.2.1 Key trends and opportunities
- 8.2.2 North America Market size and forecast, by Technology
- 8.2.3 North America Market size and forecast, by Application
- 8.2.4 North America Market size and forecast, by Animal Type
- 8.2.5 North America Market size and forecast, by End User
- 8.2.6 North America Market size and forecast, by country
  - 8.2.6.1 U.S.
  - 8.2.6.1.1 Market size and forecast, by Technology
  - 8.2.6.1.2 Market size and forecast, by Application
  - 8.2.6.1.3 Market size and forecast, by Animal Type
  - 8.2.6.1.4 Market size and forecast, by End User
  - 8.2.6.2 Canada
  - 8.2.6.2.1 Market size and forecast, by Technology
  - 8.2.6.2.2 Market size and forecast, by Application
  - 8.2.6.2.3 Market size and forecast, by Animal Type
  - 8.2.6.2.4 Market size and forecast, by End User
  - 8.2.6.3 Mexico
  - 8.2.6.3.1 Market size and forecast, by Technology
  - 8.2.6.3.2 Market size and forecast, by Application
  - 8.2.6.3.3 Market size and forecast, by Animal Type
  - 8.2.6.3.4 Market size and forecast, by End User
8.3 Europe
- 8.3.1 Key trends and opportunities
- 8.3.2 Europe Market size and forecast, by Technology
- 8.3.3 Europe Market size and forecast, by Application
- 8.3.4 Europe Market size and forecast, by Animal Type
- 8.3.5 Europe Market size and forecast, by End User
- 8.3.6 Europe Market size and forecast, by country
  - 8.3.6.1 Germany
  - 8.3.6.1.1 Market size and forecast, by Technology
  - 8.3.6.1.2 Market size and forecast, by Application
  - 8.3.6.1.3 Market size and forecast, by Animal Type
  - 8.3.6.1.4 Market size and forecast, by End User
  - 8.3.6.2 France
  - 8.3.6.2.1 Market size and forecast, by Technology
  - 8.3.6.2.2 Market size and forecast, by Application
  - 8.3.6.2.3 Market size and forecast, by Animal Type
  - 8.3.6.2.4 Market size and forecast, by End User
  - 8.3.6.3 U.K.
  - 8.3.6.3.1 Market size and forecast, by Technology
  - 8.3.6.3.2 Market size and forecast, by Application
  - 8.3.6.3.3 Market size and forecast, by Animal Type
  - 8.3.6.3.4 Market size and forecast, by End User
  - 8.3.6.4 Italy
  - 8.3.6.4.1 Market size and forecast, by Technology
  - 8.3.6.4.2 Market size and forecast, by Application
  - 8.3.6.4.3 Market size and forecast, by Animal Type
  - 8.3.6.4.4 Market size and forecast, by End User
  - 8.3.6.5 Spain
  - 8.3.6.5.1 Market size and forecast, by Technology
  - 8.3.6.5.2 Market size and forecast, by Application
  - 8.3.6.5.3 Market size and forecast, by Animal Type
  - 8.3.6.5.4 Market size and forecast, by End User
  - 8.3.6.6 Rest of Europe
  - 8.3.6.6.1 Market size and forecast, by Technology
  - 8.3.6.6.2 Market size and forecast, by Application
  - 8.3.6.6.3 Market size and forecast, by Animal Type
  - 8.3.6.6.4 Market size and forecast, by End User
8.4 Asia-Pacific
- 8.4.1 Key trends and opportunities
- 8.4.2 Asia-Pacific Market size and forecast, by Technology
- 8.4.3 Asia-Pacific Market size and forecast, by Application
- 8.4.4 Asia-Pacific Market size and forecast, by Animal Type
- 8.4.5 Asia-Pacific Market size and forecast, by End User
- 8.4.6 Asia-Pacific Market size and forecast, by country
  - 8.4.6.1 Japan
  - 8.4.6.1.1 Market size and forecast, by Technology
  - 8.4.6.1.2 Market size and forecast, by Application
  - 8.4.6.1.3 Market size and forecast, by Animal Type
  - 8.4.6.1.4 Market size and forecast, by End User
  - 8.4.6.2 China
  - 8.4.6.2.1 Market size and forecast, by Technology
  - 8.4.6.2.2 Market size and forecast, by Application
  - 8.4.6.2.3 Market size and forecast, by Animal Type
  - 8.4.6.2.4 Market size and forecast, by End User
  - 8.4.6.3 Australia
  - 8.4.6.3.1 Market size and forecast, by Technology
  - 8.4.6.3.2 Market size and forecast, by Application
  - 8.4.6.3.3 Market size and forecast, by Animal Type
  - 8.4.6.3.4 Market size and forecast, by End User
  - 8.4.6.4 India
  - 8.4.6.4.1 Market size and forecast, by Technology
  - 8.4.6.4.2 Market size and forecast, by Application
  - 8.4.6.4.3 Market size and forecast, by Animal Type
  - 8.4.6.4.4 Market size and forecast, by End User
  - 8.4.6.5 South Korea
  - 8.4.6.5.1 Market size and forecast, by Technology
  - 8.4.6.5.2 Market size and forecast, by Application
  - 8.4.6.5.3 Market size and forecast, by Animal Type
  - 8.4.6.5.4 Market size and forecast, by End User
  - 8.4.6.6 Rest Of Asia Pacific
  - 8.4.6.6.1 Market size and forecast, by Technology
  - 8.4.6.6.2 Market size and forecast, by Application
  - 8.4.6.6.3 Market size and forecast, by Animal Type
  - 8.4.6.6.4 Market size and forecast, by End User
8.5 LAMEA
- 8.5.1 Key trends and opportunities
- 8.5.2 LAMEA Market size and forecast, by Technology
- 8.5.3 LAMEA Market size and forecast, by Application
- 8.5.4 LAMEA Market size and forecast, by Animal Type
- 8.5.5 LAMEA Market size and forecast, by End User
- 8.5.6 LAMEA Market size and forecast, by country
  - 8.5.6.1 Brazil
  - 8.5.6.1.1 Market size and forecast, by Technology
  - 8.5.6.1.2 Market size and forecast, by Application
  - 8.5.6.1.3 Market size and forecast, by Animal Type
  - 8.5.6.1.4 Market size and forecast, by End User
  - 8.5.6.2 Saudi Arabia
  - 8.5.6.2.1 Market size and forecast, by Technology
  - 8.5.6.2.2 Market size and forecast, by Application
  - 8.5.6.2.3 Market size and forecast, by Animal Type
  - 8.5.6.2.4 Market size and forecast, by End User
  - 8.5.6.3 South Africa
  - 8.5.6.3.1 Market size and forecast, by Technology
  - 8.5.6.3.2 Market size and forecast, by Application
  - 8.5.6.3.3 Market size and forecast, by Animal Type
  - 8.5.6.3.4 Market size and forecast, by End User
  - 8.5.6.4 Rest of LAMEA
  - 8.5.6.4.1 Market size and forecast, by Technology
  - 8.5.6.4.2 Market size and forecast, by Application
  - 8.5.6.4.3 Market size and forecast, by Animal Type
  - 8.5.6.4.4 Market size and forecast, by End User

CHAPTER 9: COMPANY LANDSCAPE

9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Key developments

CHAPTER 10: COMPANY PROFILES

10.1 Virbac
- 10.1.1 Company overview
- 10.1.2 Company snapshot
- 10.1.3 Operating business segments
- 10.1.4 Product portfolio
- 10.1.5 Business performance
- 10.1.6 Key strategic moves and developments
10.2 Thermo Fisher Scientific, Inc
- 10.2.1 Company overview
- 10.2.2 Company snapshot
- 10.2.3 Operating business segments
- 10.2.4 Product portfolio
- 10.2.5 Business performance
- 10.2.6 Key strategic moves and developments
10.3 Zoetis, Inc
- 10.3.1 Company overview
- 10.3.2 Company snapshot
- 10.3.3 Operating business segments
- 10.3.4 Product portfolio
- 10.3.5 Business performance
- 10.3.6 Key strategic moves and developments
10.4 agrolabo spa
- 10.4.1 Company overview
- 10.4.2 Company snapshot
- 10.4.3 Operating business segments
- 10.4.4 Product portfolio
- 10.4.5 Business performance
- 10.4.6 Key strategic moves and developments
10.5 Biomerieux SA
- 10.5.1 Company overview
- 10.5.2 Company snapshot
- 10.5.3 Operating business segments
- 10.5.4 Product portfolio
- 10.5.5 Business performance
- 10.5.6 Key strategic moves and developments
10.6 BioNote Inc
- 10.6.1 Company overview
- 10.6.2 Company snapshot
- 10.6.3 Operating business segments
- 10.6.4 Product portfolio
- 10.6.5 Business performance
- 10.6.6 Key strategic moves and developments
10.7 Creative Diagnostics
- 10.7.1 Company overview
- 10.7.2 Company snapshot
- 10.7.3 Operating business segments
- 10.7.4 Product portfolio
- 10.7.5 Business performance
- 10.7.6 Key strategic moves and developments
10.8 Fujifilm Holdings Corporation
- 10.8.1 Company overview
- 10.8.2 Company snapshot
- 10.8.3 Operating business segments
- 10.8.4 Product portfolio
- 10.8.5 Business performance
- 10.8.6 Key strategic moves and developments
10.9 Heska Corporation
- 10.9.1 Company overview
- 10.9.2 Company snapshot
- 10.9.3 Operating business segments
- 10.9.4 Product portfolio
- 10.9.5 Business performance
- 10.9.6 Key strategic moves and developments
10.10 HyTest Ltd
- 10.10.1 Company overview
- 10.10.2 Company snapshot
- 10.10.3 Operating business segments
- 10.10.4 Product portfolio
- 10.10.5 Business performance
- 10.10.6 Key strategic moves and developments
10.11 Idexx Laboratories Inc
- 10.11.1 Company overview
- 10.11.2 Company snapshot
- 10.11.3 Operating business segments
- 10.11.4 Product portfolio
- 10.11.5 Business performance
- 10.11.6 Key strategic moves and developments
10.12 IDvet
- 10.12.1 Company overview
- 10.12.2 Company snapshot
- 10.12.3 Operating business segments
- 10.12.4 Product portfolio
- 10.12.5 Business performance
- 10.12.6 Key strategic moves and developments
10.13 Indical Bioscience Gmbh
- 10.13.1 Company overview
- 10.13.2 Company snapshot
- 10.13.3 Operating business segments
- 10.13.4 Product portfolio
- 10.13.5 Business performance
- 10.13.6 Key strategic moves and developments
10.14 Neogen Corporation
- 10.14.1 Company overview
- 10.14.2 Company snapshot
- 10.14.3 Operating business segments
- 10.14.4 Product portfolio
- 10.14.5 Business performance
- 10.14.6 Key strategic moves and developments
10.15 Randox Laboratories Ltd
- 10.15.1 Company overview
- 10.15.2 Company snapshot
- 10.15.3 Operating business segments
- 10.15.4 Product portfolio
- 10.15.5 Business performance
- 10.15.6 Key strategic moves and developments
10.16 Shenzhen Mindray Animal Medical Technology Co. Ltd
- 10.16.1 Company overview
- 10.16.2 Company snapshot
- 10.16.3 Operating business segments
- 10.16.4 Product portfolio
- 10.16.5 Business performance
- 10.16.6 Key strategic moves and developments
10.17 Triviumvet
- 10.17.1 Company overview
- 10.17.2 Company snapshot
- 10.17.3 Operating business segments
- 10.17.4 Product portfolio
- 10.17.5 Business performance
- 10.17.6 Key strategic moves and developments

コンパニオンアニマル診断市場：技術別、用途別、動物種別、エンドユーザー別：世界の機会分析および産業予測、2021-2031年

Companion Animal Diagnostics Market By Technology, By Application, By Animal Type, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章市場の概要

第4章コンパニオンアニマル診断市場：技術別

第5章コンパニオンアニマル診断市場：アプリケーション別

第6章コンパニオンアニマル診断市場：動物タイプ別

第7章コンパニオンアニマル診断市場：エンドユーザー別

第8章コンパニオンアニマル診断市場：地域別

第9章企業情勢

第10章企業プロファイル

LIST OF TABLES

LIST OF FIGURES

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

CHAPTER 2:EXECUTIVE SUMMARY

CHAPTER 3:MARKET OVERVIEW

CHAPTER 4: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY

CHAPTER 5: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION

CHAPTER 6: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE

CHAPTER 7: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER

CHAPTER 8: COMPANION ANIMAL DIAGNOSTICS MARKET, BY REGION

CHAPTER 9: COMPANY LANDSCAPE

CHAPTER 10: COMPANY PROFILES

コンパニオンアニマル診断市場：技術別、用途別、動物種別、エンドユーザー別：世界の機会分析および産業予測、2021-2031年

Companion Animal Diagnostics Market By Technology, By Application, By Animal Type, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場の概要

第4章 コンパニオンアニマル診断市場：技術別

第5章 コンパニオンアニマル診断市場：アプリケーション別

第6章 コンパニオンアニマル診断市場：動物タイプ別

第7章 コンパニオンアニマル診断市場：エンドユーザー別

第8章 コンパニオンアニマル診断市場：地域別

第9章 企業情勢

第10章 企業プロファイル

LIST OF TABLES

LIST OF FIGURES

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

CHAPTER 2:EXECUTIVE SUMMARY

CHAPTER 3:MARKET OVERVIEW

CHAPTER 4: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY

CHAPTER 5: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION

CHAPTER 6: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE

CHAPTER 7: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER

CHAPTER 8: COMPANION ANIMAL DIAGNOSTICS MARKET, BY REGION

CHAPTER 9: COMPANY LANDSCAPE

CHAPTER 10: COMPANY PROFILES

第1章イントロダクション

第2章エグゼクティブサマリー

第3章市場の概要

第4章コンパニオンアニマル診断市場：技術別

第5章コンパニオンアニマル診断市場：アプリケーション別

第6章コンパニオンアニマル診断市場：動物タイプ別

第7章コンパニオンアニマル診断市場：エンドユーザー別

第8章コンパニオンアニマル診断市場：地域別

第9章企業情勢

第10章企業プロファイル